LONDON, England, May 23 [Category: BizPharmaceuticals] -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release: * * * Blenrep (belantamab mafodotin) combinations receive positive CHMP opinion in relapsed/refractory multiple myeloma * Positive opinion supported by superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7 * If approved, Blenrep combinations could redefine treatment as early as first relapse  more

WASHINGTON, May 23 (TNSFR) -- The Committee for Purchase From People Who Are Blind or Severely Disabled has announced proposed deletions of various products and services from its Procurement List. These items were previously supplied by nonprofit agencies that employ individuals who are blind or have other severe disabilities. The move aims to adjust the list of goods and services procured by federal entities through these authorized sources. Among the products slated for removal are specific e  more

WASHINGTON, May 22 -- Sen. Christopher Murphy, D-Connecticut, issued the following news release: * * * Murphy, Blumenthal, Colleagues Introduce Bill To Direct Restoration And Protection Efforts Of The 5-state Connecticut River Watershed Region WASHINGTON-- U.S. Senators Chris Murphy (D-Conn.) and Richard Blumenthal (D-Conn.) joined six of their Senate colleagues in reintroducing the Connecticut River Watershed Partnership Act (CRWPA), which would formalize a partnership between federal, state  more

WILMINGTON, Delaware, May 19 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma AIRSUPRA demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone Positive full results from the BATURA Phase IIIb trial showed AstraZeneca's anti-inf  more

COLLEGE STATION, Texas, May 24 -- Texas A&M University issued the following news: * * * Texas A&M Inventor Pioneers Breakthrough Cell Therapy For Patients With ALS And Other Devastating Diseases Dr. Simrit Parmar's novel treatment shows promising results in human trials, sparks first U.S.-Saudi clinical alliance and offers hope for patients with hard-to-treat diseases. Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-sta  more

RARITAN, New Jersey, May 20 -- Johnson and Johnson Innovative Medicine (formerly the Janssen Pharmaceutical Companies of Johnson and Johnson) issued the following news release: * * * U.S. FDA Oncologic Drugs Advisory Committee votes in favor of the benefit-risk profile of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) for high-risk smoldering multiple myeloma ODAC recommendation based on the positive progression-free survival and clinical benefit in the Phase 3 AQUILA study If appro  more

MONTPELIER, Vermont, May 24 -- Gov. Phil Scott, R-Vermont, issued the following news release: * * * Facts Matter: There is a Path to Educational Transformation that Works for Students and Taxpayers Montpelier, Vt. - In November, Vermonters called for real change, following years of historic, often double-digit property tax increases, and declining student performance. In January, at the very beginning of the legislative process, Governor Scott put forward a detailed plan to transform the educ  more